Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Calliditas Therapeutics Major Shareholding Notification 2021

Mar 8, 2021

3020_iss_2021-03-08_d1925d77-da4c-487c-89f2-ab34e7a7a0bf.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Calliditas Therapeutics AB

Holder

Linc AB

Instrument

Instrument Common SE0010441584
Before the transaction
Shares 4,981,829
Voting rights 4,981,829
Transaction
Reason for major shareholding notification Buy
Date 05/03/2021
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 4,999,829
Directly held voting rights 4,999,829
Indirectly held voting rights 0
Percentage
Directly held shares 10.01135 %
Directly held voting rights 10.01135 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 10.01135 % 4,999,829
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 10.01135 % 4,999,829
Group total holdings
Voting rights
4,999,829
Percentage of voting rights 10.01135
Published
08/03/2021 14:01

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25